Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOHN S GREGG

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1760442792
CMS profile
441948
Location
INDIANA, PA

General Payments · PY2018–2024

$5,724.43

  • Reported across 320 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$264.95

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $264.95 15

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $800.27 37
PY2019 $694.43 39
PY2020 $519.68 35
PY2021 $1,086.33 65
PY2022 $1,384.42 70
PY2023 $974.35 59
PY2024 $264.95 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $15.83 02/26/2024 Food and Beverage Undisputed 01/23/2026 1111589350 CMS
AstraZeneca Pharmaceuticals LP $13.28 02/22/2024 Food and Beverage Undisputed 01/23/2026 1105891950 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.26 02/13/2024 Food and Beverage Undisputed 01/23/2026 1118142732 CMS
CVRx, Inc. $23.88 01/08/2024 Food and Beverage Undisputed 01/23/2026 1128562892 CMS
E.R. Squibb & Sons, L.L.C. $22.46 02/12/2024 Food and Beverage Undisputed 01/23/2026 1101685647 CMS
Janssen Pharmaceuticals, Inc $16.52 01/17/2024 Food and Beverage Undisputed 01/23/2026 1078151119 CMS
Janssen Pharmaceuticals, Inc $20.22 02/08/2024 Food and Beverage Undisputed 01/23/2026 1078151055 CMS
Novartis Pharmaceuticals Corporation $21.72 01/25/2024 Food and Beverage Undisputed 01/23/2026 1086854077 CMS
Novartis Pharmaceuticals Corporation $18.31 02/01/2024 Food and Beverage Undisputed 01/23/2026 1086854075 CMS
Novartis Pharmaceuticals Corporation $15.68 02/20/2024 Food and Beverage Undisputed 01/23/2026 1086854085 CMS
Novartis Pharmaceuticals Corporation $13.93 05/28/2024 Food and Beverage Undisputed 01/23/2026 1086854093 CMS
Novartis Pharmaceuticals Corporation $14.83 08/19/2024 Food and Beverage Undisputed 01/23/2026 1086854101 CMS
Novartis Pharmaceuticals Corporation $16.31 11/26/2024 Food and Beverage Undisputed 01/23/2026 1086854107 CMS
Novartis Pharmaceuticals Corporation $14.84 12/11/2024 Food and Beverage Undisputed 01/23/2026 1086854111 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $20.88 01/15/2024 Food and Beverage Undisputed 01/23/2026 1080630280 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.